BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24038120)

  • 1. Compound muscle action potential amplitude and distal potential duration in axonal neuropathy.
    Rajabally YA; Martin-Lamb D; Nicolas G
    Muscle Nerve; 2014 Jan; 49(1):146-7. PubMed ID: 24038120
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlation between compound muscle action potential amplitude and duration in axonal and demyelinating polyneuropathy.
    Tankisi H; Otto M; Pugdahl K; Johnsen B; Fuglsang-Frederiksen A
    Clin Neurophysiol; 2012 Oct; 123(10):2099-105. PubMed ID: 22560637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological patterns of diabetic polyneuropathy.
    Bagai K; Wilson JR; Khanna M; Song Y; Wang L; Fisher MA
    Electromyogr Clin Neurophysiol; 2008; 48(3-4):139-45. PubMed ID: 18551834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations of nerve conduction measures in axonal and demyelinating polyneuropathies.
    Tankisi H; Pugdahl K; Johnsen B; Fuglsang-Frederiksen A
    Clin Neurophysiol; 2007 Nov; 118(11):2383-92. PubMed ID: 17900975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conduction block and abnormal temporal dispersion--diagnostic criteria.
    Weber F
    Electromyogr Clin Neurophysiol; 1997 Aug; 37(5):305-9. PubMed ID: 9298343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower tibial than peroneal compound muscle action potential amplitude in neuromuscular diseases.
    Rubin DI; Whaley NR
    J Clin Neurophysiol; 2010 Oct; 27(5):341-3. PubMed ID: 20844444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is total duration of distal compound muscle action potential better than negative peak duration in the diagnosis of chronic inflammatory demyelinating polyneuropathy?
    Lagarde J; Viala K; Fournier E
    Muscle Nerve; 2014 Jun; 49(6):895-9. PubMed ID: 24114712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medial dorsal superficial peroneal nerve studies in patients with polyneuropathy and normal sural responses.
    Kushnir M; Klein C; Kimiagar Y; Pollak L; Rabey JM
    Muscle Nerve; 2005 Mar; 31(3):386-9. PubMed ID: 15508123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upper leg conduction time distinguishes demyelinating neuropathies.
    Maccabee PJ; Eberle LP; Stein IA; Willer JA; Lipitz ME; Kula RW; Marx T; Muntean EV; Amassian VE
    Muscle Nerve; 2011 Apr; 43(4):518-30. PubMed ID: 21319166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology inferred from electrodiagnostic nerve tests and classification of polyneuropathies. Suggested guidelines.
    Tankisi H; Pugdahl K; Fuglsang-Frederiksen A; Johnsen B; de Carvalho M; Fawcett PR; Labarre-Vila A; Liguori R; Nix WA; Schofield IS;
    Clin Neurophysiol; 2005 Jul; 116(7):1571-80. PubMed ID: 15907395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dispersion of compound muscle action potential in hereditary neuropathies and chronic inflammatory demyelinating polyneuropathy.
    Stanton M; Pannoni V; Lewis RA; Logigian EL; Naguib D; Shy ME; Cleland J; Herrmann DN
    Muscle Nerve; 2006 Oct; 34(4):417-22. PubMed ID: 16823858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The medial plantar and medial peroneal cutaneous nerve conduction studies for diabetic polyneuropathy.
    Altun Y; Demirkol A; Tumay Y; Ekmekci K; Unsal I; Koyluoglu AC; Ozkul Y
    Neurol Sci; 2011 Oct; 32(5):849-54. PubMed ID: 21720897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new differential diagnosis for acquired demyelinating neuropathy: copper deficiency.
    Karlikaya G; Kaya D
    Neurol India; 2014; 62(4):434-5. PubMed ID: 25237952
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical-neurophysiological correlations in a series of patients with IgM-related neuropathy.
    Luigetti M; Padua L; Mazza S; Rossini PM; Sabatelli M; Lo Monaco M
    Clin Neurophysiol; 2013 Sep; 124(9):1899-903. PubMed ID: 23643315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of atrophy of foot muscles in diabetic neuropathy -- a comparative study of nerve conduction studies and ultrasonography.
    Severinsen K; Andersen H
    Clin Neurophysiol; 2007 Oct; 118(10):2172-5. PubMed ID: 17709290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Firing patterns of single motor units in the early stage of demyelinating neuropathy (author's transl)].
    Dietz V; Freund HJ
    J Neurol; 1974; 207(4):255-69. PubMed ID: 4138540
    [No Abstract]   [Full Text] [Related]  

  • 17. Distal nerve excitability and conduction studies in a case of rapidly regressive acute motor neuropathy with multiple motor conduction blocks.
    Boërio-Guéguen D; Ahdab R; Ayache SS; Kerschen P; André C; Créange A; Lefaucheur JP
    J Peripher Nerv Syst; 2010 Dec; 15(4):369-72. PubMed ID: 21199109
    [No Abstract]   [Full Text] [Related]  

  • 18. Differentiation between uniform and non-uniform motor nerve conduction slowing.
    Busch V; Schulte-Mattler WJ
    Clin Neurophysiol; 2010 Jun; 121(6):890-4. PubMed ID: 20227911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case of acute motor conduction block neuropathy (AMCBN).
    Manganelli F; Pisciotta C; Iodice R; Calandro S; Dubbioso R; Ranieri A; Santoro L
    Muscle Nerve; 2009 Feb; 39(2):224-6. PubMed ID: 19145655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current perception threshold: an adjunctive test for detection of acquired demyelinating polyneuropathies.
    Menkes DL; Swenson MR; Sander HW
    Electromyogr Clin Neurophysiol; 2000 Jun; 40(4):205-10. PubMed ID: 10907597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.